Alerts will be sent to your verified email
Verify EmailBDH
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
BDH Industries Limited specializes in Oral Solid Dosages (OSD) technologies with a focus on Novel Drug Delivery System (NDDS). The company's successful products have passed regulatory tests in multiple countries.
BDH Inds major competitors are Oxygenta Pharma, Speciality Medicines, Lyka Labs, Astonea Labs, Accretion Nutraveda, Nectar Lifesciences, Parnax Lab.
Market Cap of BDH Inds is ₹210 Crs.
While the median market cap of its peers are ₹207 Crs.
BDH Inds seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.